Panel discussion on new technologies in lymphoma - the applications of circulating tumor DNA
Ash Alizadeh et al.
What’s new in minimal residual disease (MRD) detection in myeloma?
Open questions in the use of imaging techniques for assessing response in multiple myeloma
Treating lymphoma beyond progression
The pros and cons of MRI and PET-CT for assessing response in multiple myeloma